Suven Life Sciences Limited SUVEN.NS Open Suven Life Sciences Limited in new tab
Suven Life Sciences Limited Analysis (SUVEN.NS)
Is Suven Life Sciences Limited a good investment? Suven Life Sciences Limited (SUVEN.NS) is currently trading at 157.96 INR.
Earnings Schedule: Suven Life Sciences Limited is expected to release its next earnings report on May 11, 2026. The market consensus estimate for Forward EPS is 19.35.
Investor FAQ
Does Suven Life Sciences Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Suven Life Sciences Limited?
Suven Life Sciences Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 11, 2026. The company currently has a trailing EPS of -12.31.
Company Profile
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for treating sleep and cognitive disorders; and Ropanicant (SUVN-911), an Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is also developing Usmarapride (SUVN-D4010), a bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for treating cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for treating gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited operates as a subsidiary of Jasti Property and Equity Holdings Private Limited.
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2019 | 1.50 INR |
| Feb. 25, 2019 | 1.5000 |
| 2018 | 1.50 INR |
| March 1, 2018 | 1.5000 |
| 2017 | 1.00 INR |
| March 3, 2017 | 1.0000 |
| 2016 | 1.00 INR |
| March 23, 2016 | 1.0000 |
| 2015 | 0.60 INR |
| Sept. 13, 2015 | 0.6000 |
| 2014 | 0.46 INR |
| July 24, 2014 | 0.4607 |
| 2013 | 0.30 INR |
| Sept. 12, 2013 | 0.3000 |
| 2012 | 0.30 INR |
| Oct. 27, 2012 | 0.3000 |
| 2011 | 0.25 INR |
| Sept. 12, 2011 | 0.2500 |
| 2010 | 0.25 INR |
| Aug. 26, 2010 | 0.2500 |
| 2009 | 0.25 INR |
| Oct. 22, 2009 | 0.2500 |
| 2008 | 0.25 INR |
| Oct. 1, 2008 | 0.2500 |
| 2007 | 0.25 INR |
| Nov. 1, 2007 | 0.2500 |
| 2006 | 0.46 INR |
| Oct. 12, 2006 | 0.4606 |
| 2005 | 0.46 INR |
| Sept. 5, 2005 | 0.4606 |
| 2004 | 0.46 INR |
| Sept. 10, 2004 | 0.4606 |
Yearly aggregated dividends
Dividends
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| March 23, 2007 | 2.000000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion